WP
ABVX

Woodline Partners’s Abivax ABVX Stock Holding History

Woodline Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2M Buy
226,966
+1,074
+0.5% +$122K 0.09% 278
2026
Q1 		$25.2M Hold
225,892
– – 0.1% 282
2025
Q4 		$30.5M Sell
225,892
-85,150
-27% -$9.29M 0.12% 225
2025
Q3 		$26.4M Buy
311,042
+127,242
+69% +$7.8M 0.12% 220
2025
Q2 		$1.41M Sell
183,800
-18,124
-9% -$118K 0.01% 767
2025
Q1 		$1.26M Buy
201,924
+153,788
+319% +$1.04M 0.01% 736
2024
Q4 		$352K Sell
48,136
-33,594
-41% -$309K ﹤0.01% 873
2024
Q3 		$942K Buy
81,730
+50,446
+161% +$604K 0.01% 511
2024
Q2 		$414K Buy
+31,284
New +$447K ﹤0.01% 504

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Woodline Partners's ABVX Position: Q2 2026 in Review

Woodline Partners increased its Abivax (ABVX) stake by 0.48% in Q2 2026, buying an estimated $122K and bringing the position to 226,966 shares worth $30.2M. The position accounts for 0.09% of the portfolio, ranked #278.

Woodline Partners first reported a position in ABVX in Q2 2024 and has held it in 9 quarters since. The position peaked at $30.5M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Woodline Partners held 226,966 shares of Abivax worth $30.2M as of Q2 2026.
  • Woodline Partners bought 1,074 Abivax shares in Q2 2026, an estimated $122K.
  • Abivax made up 0.09% of Woodline Partners's portfolio in Q2 2026, its #278 holding.
  • Woodline Partners first reported a position in Abivax in Q2 2024 and has held it in 9 quarters since.
  • Woodline Partners's Abivax position peaked at $30.5M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.